Skip to content
Home/Companies/HealthTech/Fytexia

Fytexia

HealthTech·France·Exited 2023·Held 7yr
Entry
2016
Hold
7yr
Exit
2023

Who owns Fytexia?

Fytexia is a French HealthTech company, now owned by Associated British Foods, which acquired it in 2023 from ARCHIMED.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

HQFrance
SectorHealthTech
Key takeaways
  • ·Fully exited in 2023 to Associated British Foods.
  • ·Best return: 4.0x MOIC by ARCHIMED (2023 exit).
Exit Type
Trade Sale
Buyer
Associated British Foods
MOIC
4.0x
Exit Year
2023

More from MED I

Other portfolio companies in the same fund.

Stago
Stago
Active
MedTechFrance· 2026
Micromed
Micromed
Exited 2023
MedTechFrance· 2016
to Natus Medical (ARCHIMED portfolio company, intra-portfolio)
Natural Origins
Natural Origins
2.5xExited 2017
HealthTechFrance· 2016
to Dohler Group
Polyplus
Polyplus
300.0xExited 2023
BiotechFrance· 2016
to Sartorius Stedim
Deallus
Exited 2024
PharmaUK· 2015
to GlobalData Plc
Primo Group
Primo Group
3.0xExited 2024
HealthTechItaly· 2015
to Aksia

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Fytexia?

Fytexia is now owned by Associated British Foods, which acquired it in 2023 from ARCHIMED.

When did Associated British Foods acquire Fytexia?

Associated British Foods acquired Fytexia in 2023, buying from ARCHIMED.

Who did Fytexia sell to?

ARCHIMED sold Fytexia to Associated British Foods in 2023 (Trade Sale), 4.0x return.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue